Centessa Pharmaceuticals Plc ADR
(CNTA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -50,714 | -216,207 | -173,034 | -119,159 | -54,498 |
| Depreciation Amortization | 89 | 131 | 95 | 60 | 28 |
| Income taxes - deferred | N/A | -2,857 | -83 | 52 | N/A |
| Accounts payable and accrued liabilities | -1,815 | 6,351 | 3,755 | 623 | -1,220 |
| Other Working Capital | -6,203 | -2,658 | 11,212 | 4,152 | -2,345 |
| Other Operating Activity | 10,805 | 14,694 | 9,073 | 4,378 | 8,018 |
| Operating Cash Flow | $-47,838 | $-200,546 | $-148,982 | $-109,894 | $-50,017 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -86,248 | N/A | N/A | N/A | N/A |
| PPE Investments | -88 | -1,137 | -485 | -469 | -240 |
| Other Investing Activity | 0 | 206 | 0 | 0 | 0 |
| Investing Cash Flow | $-86,336 | $-931 | $-485 | $-469 | $-240 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 718 | 629 | 405 | 335 |
| Other Financing Activity | 0 | -261 | -261 | -261 | -261 |
| Financing Cash Flow | $N/A | $457 | $368 | $144 | $74 |
| Exchange Rate Effect | 518 | -418 | -1,140 | -702 | -434 |
| Beginning Cash Position | 393,644 | 595,082 | 595,082 | 595,082 | 595,082 |
| End Cash Position | 259,988 | 393,644 | 444,843 | 484,161 | 544,465 |
| Net Cash Flow | $-133,656 | $-201,438 | $-150,239 | $-110,921 | $-50,617 |
| Free Cash Flow | |||||
| Operating Cash Flow | -47,838 | -200,546 | -148,982 | -109,894 | -50,017 |
| Capital Expenditure | -88 | -1,137 | -485 | -469 | -240 |
| Free Cash Flow | -47,926 | -201,683 | -149,467 | -110,363 | -50,257 |